2022 Seminars
December 19
Matthew W. Johnson, Ph.D.
Johns Hopkins School of Medicine
"Psychedelic Treatment of Tobacco Use Disorders"
November 21
Matthew S. Salzman, M.D. and Lindsay Wilson, LPN
Cooper Health /School of Medicine
"Using long-acting, injectable buprenorphine to battle the opioid crisis"
October 17
Panel: PHMC: Joan LeJoie; Mary Kremer; The Consortium: Darryl Flynn; Moderator: Anna Rose Childress
"From the frontlines of the OUD Crisis in Philadelphia"
September 30
The 3rd annual PACE Day was held at the University of Pennsylvania. Sara Jones, Ph.D. of Wake Forest School of Medicine gave the Malison Lecture: "Drug-Induced Dopamine Adaptations: A View from the Presynapctic Terminal"
The agenda can be found Here
June 27
Kosta Plakas, Ph.D.
Journal Club
"Naloxone's dose -dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain"
June 6
Daniel M. Blonigen, Ph.D.
Stanford University
"Use of mobile health tools and peer-based interventions to increase access and engagement in care among justice involved and homeless Veterans"
May 26
Rachel Vickers-Smith, Ph.D., MPH
University of Kentucky School of Public Health
"Racial and ethnic disparities in the diagnosis of AUD, and in the treatment of OUD with buprenorphine"
May 9
Ashish Thrakar, M.D. UPenn Internal Medicine & Addiction Medicine
University of Pennsylvania
"Opioid Use Disorder (OUD) in the fentanyl era: Emerging clinical challenges"
April 11
Jason Wallach, Ph.D. Assistant Professor of Pharmaceutical Sciences
University of the Sciences (Philadelphia)
"The therapeutic promise of 5HT2A (psilocybin-like) agonists in psychiatric treatment"